Summary
President Trump signed an executive order that allows a new program for Medicare to cover certain cannabis products for seniors. This pilot program reclassifies marijuana to make it easier for Medicare to pay for CBD, a cannabis product, expected to start in April next year.
Key Facts
- President Trump signed an executive order for Medicare to cover CBD products for seniors.
- Marijuana was reclassified as a Schedule III drug, similar to certain prescription medications.
- Use of marijuana among adults aged 65 or older is increasing in the U.S.
- Coverage of CBD products will begin as early as April next year for Medicare enrollees.
- The Department of Health & Human Services is considering loosening restrictions on cannabis.
- CMS might expand coverage if the pilot program shows positive results.
- Research indicates CBD helps with anxiety, insomnia, and chronic pain but could have side effects.
- Some experts believe cannabinoid therapies are cost-effective and less harmful than some existing medications.
